top of page

CanVasc Members Publications 2026

Discover the latest research  from CanVasc members!  

The 2026 publications are listed in chronological order.  

JANUARY

​

  • Drug- and vaccine induced ANCA-associated vasculitis: An overview.  

Cohen Tervaert, J. W. (2026a, Jan). Autoimmun Rev, 25(1), 103924. https://doi.org/10.1016/j.autrev.2025.103924 

 

  • Prophylactic trimethoprim-sulfamethoxazole in anti-neutrophil cytoplasmic autoantibody-associated vasculitis: comment on the article by Kim et al. 

Cohen Tervaert, J. W. (2026b, Jan). Arthritis Rheumatol, 78(1), 260-261. https://doi.org/10.1002/art.43296 

 

  • Navigating the Roadblocks: National Patient and Provider Survey on Barriers to Healthcare and Medication Access for Patients With Vasculitis.

Nanda, K., Mathura, P., Burns, K. K., Pagnoux, C., Stewart, J. et Yacyshyn, E. (2026, Jan 1). J Rheumatol, 53(1), 62-67. https://doi.org/10.3899/jrheum.2025-0640 

 

  • Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis.  

Dong, C., Lu, B., Zhong, C., Ou, C., Yang, X., Wang, L., Zuo, X., Xue, L., Lu, C., Wang, S., Wen, J., Ma, J., Deng, Z., Liu, Y., Ma, L., Liu, M., Lew, A. M., Mukherjee, M., Nair, P., Zhong, N., Chen, R., Chen, Z., Zhang, Y. et Zhang, Q. (2026, Jan 7). Nat Commun, 17(1), 1346. https://doi.org/10.1038/s41467-025-68104-6 

 

FEBRUARY

 

  • Treatment Patterns and Clinical Outcomes for Patients Living with Active Giant Cell Arteritis in Canada. 

Makhzoum, J. P., Avadisian, M. et Liazoghli, D. (2026, Feb). Rheumatol Ther, 13(1), 243-263. https://doi.org/10.1007/s40744-025-00817-y 

 

  • Management of antineutrophil cytoplasmic antibody vasculitis-associated orbital inflammatory disease: A systematic literature review.  

Neary, E., Healey, K., Clements-Baker, M., Makhzoum, J. P. et Mendel, A. (2026, Feb). Semin Arthritis Rheum, 76, 152900. https://doi.org/10.1016/j.semarthrit.2025.152900 

 

  • Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated Vasculitis.  

Hanberg, J. S., Zhang, Y., Kronbichler, A., Matyjek, A., McAlear, C., Odler, B., Uchida, L., Geetha, D., Hawley, C., Jayne, D., Walsh, M., Merkel, P. A. et Wallace, Z. S. (2026, Feb 1). Clin J Am Soc Nephrol, 21(2), 283-295. https://doi.org/10.2215/cjn.0000000881 

 

  • Clinician views concerning the prevalence and impact of granulomas on the diagnosis, management, and outcomes of ANCA-associated vasculitis.  

Junek, M., Fussner, L. A., Mendel, A., Jayne, D., Merkel, P. A. et Walsh, M. (2026, Feb 4). Rheumatology (Oxford), 65(2). https://doi.org/10.1093/rheumatology/keaf585 

 

  • Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model.  

Nehme, A., Sylaja, P. N., Isabel, C., Capron, J., Arquizan, C., Régent, A., Guillon, B., Dequatre, N., Detante, O., Casolla, B., Levraut, M., Gollion, C., Kremer, L., Lambert, N., Derex, L., Humbertjean, L., Denier, C., Kerschen, P., Saadoun, D., Vannier, S., Sibon, I., Maarouf, A., Weisenburger-Lile, D., Sellimi, A., Mazighi, M., Lanthier, S., Poppe, A. Y., Mathon, B., Boulouis, G., Godard, S., Terrier, B., Aouba, A., Zuber, M., Sundaram, S., Paramsivam, N., Briant, A., Parienti, J. J., Touzé, E., Pagnoux, C. et de Boysson, H. (2026, Feb 4). Rheumatology (Oxford), 65(2). https://doi.org/10.1093/rheumatology/keaf590 

 

  • Risk factors for acute coronary syndrome in patients with giant cell arteritis: a scoping review. 

Pelletier, E., Kanters, C., Ducharme-Bénard, S. et Makhzoum, J. P. (2026, Feb 25). Ther Adv Musculoskelet Dis, 18, 1759720x261425813. https://doi.org/10.1177/1759720x261425813 

 

MARCH

 

  • Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis.  

Mukherjee, M., Tan, N. S., Huang, C., Kim, B., Radford, K., Ju, X., Venegas Garrido, C., Kjarsgaard, M., Rodríguez-Suárez, E., Wechsler, M. E., Walker, B., Börjesson Sjö, L., Necander, S., Ashkar, A., Weidner, J., Sehmi, R., McCrae, C., Khalidi, N. et Nair, P. (2026, Mar). ERJ Open Res, 12(2). https://doi.org/10.1183/23120541.01134-2025 

 

  • The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis.  

Nair, P. K., Hellmich, B., Bourdin, A., Jayne, D. R. W., Roufosse, F., Khalidi, N., Börjesson Sjö, L., Fan, Y., McCrae, C., Necander, S., Rodríguez-Suárez, E., Shavit, A., Walton, C., Merkel, P. A. et Wechsler, M. E. (2026, Mar). Arthritis Rheumatol, 78(3), 695-704. https://doi.org/10.1002/art.43398 

 

  • Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study.  

Pallotti, F., Mettler, C., Papo, M., Iudici, M., Padoan, R., Sorin, B., Regola, F., Franceschini, F., Moiseev, S., Novikov, P., Piga, M. A., Moroncini, G., Brix, S. R., Kafagi, A. H., Deshayes, S., Aouba, A., Campagne, J., Delvino, P., Tervaert, J. W. C., Brussino, L., Michaud, M., Venhoff, N., Alberici, F., Iannone, C., Rosenstingl, S., Moutel, M., Galempoix, J. M., Cottin, V., Jaccard, C., Riehl, D., Legendre, P., Billet, A. C., Parronchi, P., Quartuccio, L., Teixeira, V., Egan, A., Jayne, D., Tombetti, E., Caminati, M., Pagnoux, C., Regent, A., Ruivard, M., Guillevin, L., Puéchal, X. et Terrier, B. (2026, Mar). J Intern Med, 299(3), 349-364. https://doi.org/10.1111/joim.70056 

 

  • Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors.  

Trivioli, G., Allinovi, M., Di Marcantonio, E., Jawa, N. A., Trivelli, A., Yang, J., Grenda, R., Rubik, J., Mohammad, A. J., Testa, S., Jahnukainen, T., Gulhan, B., Topaloglu, R., Puéchal, X., Kosałka-Węgiel, J., Dursun, I., Guzzo, I., Pasini, A., Kostik, M. M., Oni, L., Buti, E., Becherucci, F., Palazzini, G., Moroni, G., Ozen, S., Laurent, A., Harambat, J., Dossier, C., Marks, S. D., Bruchfeld, A., Lugli, G., Bettiol, A., Emmi, G., Romagnani, P., Saleem, M. A., Ware, N., Zhou, J., Teoh, C. W., Ghiggeri, G. M., Noone, D. et Vaglio, A. (2026, Mar 1). Clin J Am Soc Nephrol, 21(3), 480-493. https://doi.org/10.2215/cjn.0000000936 

 

  • Hydralazine Use and Risk of  Vasculitis.  

Fremont, D., Dhaliwal, S., Canney, M., Akbari, A., Hundemer, G. L., Derebail, V. K., Sood, M. M. et Massicotte-Azarniouch, D. (2026, Mar 16). JAMA Netw Open, 9(3), e261943. https://doi.org/10.1001/jamanetworkopen.2026.1943 

 

  • Comprehensive immune profiling identifies alterations in adaptive and innate immune responses in granulomatosis with polyangiitis patients in remission.  

Liu, M., Duan, D., Li, C., Hu, X., Huang, J., Tang, Y., Palayew, S., Zhang, L., Pagnoux, C., Guidos, C., Zhang, J. et Siminovitch, K. (2026a, Mar 26). Front Immunol, 17, 1726107. https://doi.org/10.3389/fimmu.2026.1726107 

 

APRIL

 

  • Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis.  

Junek, M., Choi, S., Garner, S., Rawn, S., Cox, G., Khalidi, N., Cuthbertson, D., Koening, C. L., Langford, C. A., McAlear, C. A., Monach, P. A., Moreland, L. W., Pagnoux, C., Seo, P., Specks, U., Warrington, K. J. et Merkel, P. A. (2026, Apr). Semin Arthritis Rheum, 77, 152949. https://doi.org/10.1016/j.semarthrit.2026.152949 

 

  • Is ANCA-Associated Vasculitis Ready for Personalized Medicine?  

Popa, C. A. et Walsh, M. (2026, Apr). Kidney Int Rep, 11(4), 106349. https://doi.org/10.1016/j.ekir.2026.106349 

 

  • 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis.  

Quinn, K. A., Tan, S., Verdijk, P., Okonkwo, L., Samson, M., Blockmans, D., Makhzoum, J. P., Cid, M. C., Henes, J., Schönau, V., Ahlman, M. A. et Grayson, P. C. (2026, Apr 6). Arthritis Rheumatol. https://doi.org/10.1002/art.70166 

 

  • Risk and trends of severe infection in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a two-part population-based trajectory analysis.  

Zhao, K., Aviña-Zubieta, J. A., Dehghan, N., Esdaile, J. M. et Xie, H. (2026, Apr 8). Clin Rheumatol, 45(6), 3597-3607. https://doi.org/10.1007/s10067-026-08096-w 

 

  • Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.  

Cabral, D. A., Bosman, E. S., McPhate, N., Mann, S. K., Toor, K. K., Morishita, K. A., Luqmani, R., Beresford, M. W., Bistolarides, J., Campillo, S., Charuvanij, S., Cook, K., Dancey, P., de Guzman, M., Deepak, S., Eberhard, B., Elder, M., Gagne, S., Harrison, K., Huber, A., Khan, A., Kim, S., Klein-Gitelman, M. S., Lee, T. C., Li, S. C., Martin, N., McErlane, F., Moorthy, L. N., Orjuela, A. H., Park, J., Riley, P., Rosenberg, A. M., Shenoi, S., Sivaraman, V., Sutnga, S., Tanner, T., Tarvin, S. E., Twilt, M., Wagner-Weiner, L., Yeung, R. S. M. et Brown, K. L. (2026, Apr 9). Arthritis Rheumatol. https://doi.org/10.1002/art.70172 

 

  • Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis-Time to Reconsider?  

Marquis-Gravel, G. et Makhzoum, J. P. (2026, Apr 17). JAMA Netw Open, 9(4), e266587. https://doi.org/10.1001/jamanetworkopen.2026.6587 

 

  • Effect of vitamin D treatment in ANCA-associated vasculitis: results from an exploratory perspective, pragmatic, non-randomised study.  

Basti, A., Zgaga, L., Doubelt, I., Soowamber, M. et Pagnoux, C. (2026, Apr 22). Clin Exp Rheumatol, 44(4), 767-773. https://doi.org/10.55563/clinexprheumatol/1tgx6e 

 

MAY

 

  • Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey. 

Conticini, E., Emmi, G., Grazzini, S., André, M., Cohen Tervaert, J. W., Durante, E., Torracca, F., Mohammad, A. J., Moosig, F., Neumann, T., Solans Laque, R., Terrier, B., Vaglio, A. et Cameli, P. (2026, May). Rheumatology (Oxford), 65(5). https://doi.org/10.1093/rheumatology/keag218 

 

  • A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis.  

Makhzoum, J. P., Cid, M. C., Samson, M., Henes, J., Schönau, V., Espigol-Frigole, G., Ross, C., Ahlman, M. A., Hsu, M. C., Li, S., Verdijk, P., Okonkwo, L., Grayson, P. C. et Blockmans, D. (2026, May). Ann Rheum Dis, 85(5), 911-920. https://doi.org/10.1016/j.ard.2026.01.009 

 

  • Multisystem inflammatory syndrome in children is a SARS-CoV-2 triggered Kawasaki disease.  

Mastrangelo, G., Tsoukas, P., Go, E., Lu, H., Cheng, A. H. H., Xu, A. et Yeung, R. S. M. (2026, May). Pediatric Research, 99(6), 2267-2273. https://doi.org/10.1038/s41390-025-04499-8 

 

  • Correction: Comprehensive immune profiling identifies alterations in adaptive and innate immune responses in granulomatosis with polyangiitis patients in remission.  

Liu, M., Duan, D., Li, C., Hu, X., Huang, J., Tang, Y., Palayew, S., Zhang, L., Pagnoux, C., Guidos, C., Zhang, J. et Siminovitch, K. (2026b, May 12). Front Immunol, 17, 1874627. https://doi.org/10.3389/fimmu.2026.1874627 

 

JUNE

 

  • Janus Kinase Inhibitors in Eosinophilic Granulomatosis With Polyangiitis: An International Case Series.  

Russo, P. A. J., Makhzoum, J. P., Cottin, V., Conticini, E., Emmi, G. et Whittle, S. L. (2026, Jun). J Rheumatol, 53(6), 708-712. https://doi.org/10.3899/jrheum.2025-1128 

 

  • Streamlining Kawasaki disease care: a quality improvement initiative to safely reduce length of stay.  

Chen, A., Gamulka, B. D., Alkhdher, H., Palomer, M. et Yeung, R. S. M. (2026, Jun). Paediatr Child Health, 31(4), 319-325. https://doi.org/10.1093/pch/pxag001 

 

  • Thromboembolic events in giant cell arteritis: a scoping review.  

Tayler-Gomez, A., Chagnon, I., Routhier, N., Zarka, F., Ducharme-Bénard, S. et Makhzoum, J. P. (2026, Jun). Ann Med Surg (Lond), 88(6), 3398-3403. https://doi.org/10.1097/ms9.0000000000005046 

 

  • Interleukin-5, Eosinophils, and Interleukin-5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis.  

Berti, A. et Pagnoux, C. (2026, Jun). Arthritis Rheumatol, 78(6), 1196-1205. https://doi.org/10.1002/art.43409 

 

  • Single Nucleotide Polymorphisms and Their Association with Coronary Artery Aneurysms and IVIG Resistance in Kawasaki Disease in Ireland.  

Duignan, S. M., Brennan, K., Connolly, E., Watson, A., Noone, D., Dunne, E., Gavin, P., Flinn, A., C, Ó. M., Doyle, S. L. et McMahon, C. J. (2026, Jun). Pediatric Cardiology, 47(5), 2018-2028. https://doi.org/10.1007/s00246-025-03989-0 

 

  • Values, preferences, and informational needs of individuals living with ANCA-associated vasculitis: a systematic review.  

Junek, M., Choi, S., Qi, Y., Al-Magooshi, A. S. A., Guyatt, G., Thabane, L., Mendel, A., Khalidi, N. et Walsh, M. (2026, Jun 12). Rheumatol Adv Pract, 10(3), rkag057. https://doi.org/10.1093/rap/rkag057 

 

JULY

 

  • Kawasaki disease: practical guidance on diagnosis and management.  

Chen, A., Rozenblyum, E., Dahdah, N., Lang, B., Scuccimarri, R., Lahiry, P., Tam, H., Chan, M., Human, A., Lee, J., Wong, P., Tsoukas, P. et Yeung, R. S. M. (2026, Jul). Paediatr Child Health, 31(5), 550-555. https://doi.org/10.1093/pch/pxag014 

 

  • Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.  

Borrego-Yaniz, G., Fuentes-Moreno, V., Ortiz-Fernández, L., Hernández-Rodríguez, J., Mackie, S. L., Vaglio, A., Castañeda, S., Solans, R., Mestre-Torres, J., Khalidi, N., Langford, C. A., Ytterberg, S., Beretta, L., Govoni, M., Emmi, G., Cimmino, M. A., Witte, T., Neumann, T., Holle, J., Schönau, V., Pugnet, G., Papo, T., Haroche, J., Mahr, A., Mouthon, L., Molberg, Ø., Diamantopoulos, A. P., Voskuyl, A., Daikeler, T., Berger, C. T., Molloy, E. S., van Sleen, Y., Sorensen, L., Luqmani, R., Ortego-Centeno, N., Brouwer, E., Lamprecht, P., Klapa, S., Salvarani, C., Merkel, P. A., Cid, M. C., Iles, M. M., González-Gay, M. A., Morgan, A. W., Martin, J. et Márquez, A. (2026, Jul 3). Ann Rheum Dis. https://doi.org/10.1016/j.ard.2026.06.008 

 

  • Beyond Just Inflammation: An Immunophenotyping Compass to Define the Clinical Pathophysiology and Guide the Management of  Takayasu Arteritis.  

Zanella, L., Chung, J., Ouzounian, M. et Seidman, M. A. (2026, Jul 21). Can J Cardiol. https://doi.org/10.1016/j.cjca.2026.07.360 

 

AUGUST

 

  • Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study. 

Mendel, A., Barra, L., Behlouli, H., Bernatsky, S., Clifford, A. H., Cohen Tervaert, J. W., Dehghan, N., Fifi-Mah, A., Makhzoum, J. P., Meunier, R. S., Milman, N., Soowamber, M., Yacyshyn, E., Khalidi, N. et Pagnoux, C. (2026, Aug). ACR Open Rheumatol, 8(8), e90119. https://doi.org/10.1002/acr2.90119 

 

  • French guidelines for the diagnosis and management of primary central nervous system vasculitis.  

de Boysson, H., Boulouis, G., Alamowitch, S., Arquizan, C., Darbon, R., Deiva, K., Edjlali, M., Humbertjean, L., Lanthier, S., Marignier, R., Mathon, B., Mellerio, C., Mokhtari, K., Néel, A., Pagnoux, C., Papo, T., Régent, A., Rodriguez-Régent, C., Stéphan, J. L., Toulaimat, L., Zuber, M. et Nehme, A. (2026, Aug). Rev Med Interne, 47(8), 430-452. https://doi.org/10.1016/j.revmed.2026.07.007 

 

  • Clinical and Laboratory Transition Between GPA and EGPA.  

Fedosenko, S. V., Junek, M., Garrido, C. V., Thawanaphong, S., Tan, N. S., Svenningsen, S., Mukherjee, M., Khalidi, N. et Nair, P. (2026, Aug). Chest, 170(2), e39-e45. https://doi.org/10.1016/j.chest.2026.03.039 

 

  • Digital [(18)F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis.  

Abikhzer, G., Roy, A., Samson, M., Dendukuri, N., Makhzoum, J. P., Stein, M. A., Hudson, M., Rousseau, É., Nienhuis, P. H., Van der Geest, K. S. M., Pineau, C., Liang, P., Levin, L. A., Slart, R. et Alberini, J. L. (2026, Aug 21). Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-026-08131-7 

 

SEPTEMBER

 

  • Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review.  

Sharma, A., Li, A. Y., Kishibe, T., Wong, D., Sanders, K. M., Jiang, M., Lee, H., Song, C., McIntyre, K., Pagnoux, C., Chan, Y., Lee, J. M. et Lee, D. J. (2026, Sep). Int Forum Allergy Rhinol, 16(9), 996-1011. https://doi.org/10.1002/alr.70217 

 

  • Therapeutic Drug Monitoring of Rituximab to Predict Early B-Cell Repopulation in Children With Inflammatory Diseases.  

Alsulami, R. A., Chugani, B., Johnstone, J., Yeh, E. A., Yeung, R. S. M., Loeff, F. C., Hiraki, L. T., Knight, A. M., Levy, D. M. et Verstegen, R. H. J. (2026, Sep 1). J Rheumatol, 53(9), 1013-1018. https://doi.org/10.3899/jrheum.2025-0890 

 

  • Drug-associated central nervous system vasculitis and reversible cerebral vasoconstriction syndrome: A global disproportionality analysis of the WHO pharmacovigilance database (VigiBase).  

Chretien, B., Deshayes, S., Muraoka, S., Nishida, K., Alexandre, J., Pagnoux, C., Aouba, A., Nehme, A., Ducros, A. et de Boysson, H. (2026, Sep 8). Br J Clin Pharmacol. https://doi.org/10.1002/bcp.70789 

 

  • Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.  

Junek, M., Ibrahim, Q., Merkel, P. A., Vilayur, E., Wald, R., Fairhead, T., Massicotte-Azarniouch, D., Girard, L., Pagnoux, C., Khalidi, N., Jayne, D. et Walsh, M. (2026, Sep 23). Ann Rheum Dis. https://doi.org/10.1016/j.ard.2026.08.020 

 

OCTOBER

 

  • Sleep disturbances in patients with vasculitis. 

Tanaka, M., Stranges, S., Speechley, K., Garcia, O. E., Mason, M., Borchin, R., Burroughs, C., Yeung, C., Gordon, J., Gurubhagavatula, I., Pagnoux, C., Merkel, P. A. et Barra, L. (2026, Oct). Sleep Med, 146, 109097. https://doi.org/10.1016/j.sleep.2026.109097 

 

  • Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.  

Clifford, A. H., Thai, J., Yip, A., Homik, J., Vandermeer, B., Kung, J. Y. et Cohen Tervaert, J. W. (2026, Oct). J Rheumatol. https://doi.org/10.3899/jrheum.2026-0050 

© 2021 by Vasculitis Clinic. Update Dec 2021 (Dr Makhzoum)

  • Facebook
bottom of page